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Abstract: BCSO is effective as an anti-aging agent in cultures of endothelial and macrophage exposed 7.12, 
dimethyl-benzantracene  (DMBA). Reactive radicals damage endothelial tissue, cause inflammatory 
reactions and have a role in carcinogenesis. Excessive eNOS expression linked to chronic inflammation and 
carcinogenesis of lung cancer. The research objective was to determine the effect of BCSO on the expression 
of eNOS and NO levels of macrophage SD rats exposed DMBA. 
A study used 36 rats SD that divided into 6 groups, given BCSO (0,01, 0,05 and 0.1 ml / day), positive, 
negative and normal control. Variables were serum levels of NO and eNOS expression in endothelial tissue.  
The results showed that eNOS expression in DMBA group is higher than the normal group (P <0.05). 
BCSO will decrease eNOS expression and NO levels. ENOS expression and NO levels in group BCSO 0,01 and 
0,05 ml / kg body weight / day lower than the DMBA group (p <0.05), and similar to the normal group (P> 
0.05). Conclusion: a dose BCSO can degrade endothelial eNOS expression and NO levels of macrophage 
culture supernatant SD rat DMBA induced. 
 
Key words: Antiaging, black cumin seed oil, degenerative diseases, the prevention of cardiovascular 
disease. 
 
 
1. Introduction 
The endogenous antioxidant system involved Nrf2 as a transcription factor and endothelial nitric oxide 
syntase (eNOS) [1]. ENOS enzyme, nitric oxide (NO) and reactive oxygen species (ROS) has a role in 
regulating the function and structure of blood vessels including the angiogenesis [2]. Endothelial cells 
produce nitric oxide (NO). Nitric oxide (NO) in vivo increases in carcinoma angiogenesis [3]-[5]. 
Exposure to reactive radicals, such as 7.12, dimethylbenzantracene (DMBA), increased eNOS expression 
and NO production [6]-[8]. Overexpression eNOS linked to chronic inflammation and carcinogenesis 
[9]-[11]. Antioxidative and antiangiogenesis compounds inhibit carcinogenesis [9], [12]. 
Black cumin seed oil contains unsaturated fatty linoleic and linolenic, thymoquinone, nigelon and nigelin 
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that are antioxidative [13], [14]. Thymoquinone is a powerful antioxidant, chemo preventive and 
immunomodulators [15]-[19]. Giving BCSO before and during DMBA induced in SD rats will inhibit 
mammary carcinogenesis carcinoma [1]. BCSO chemo preventive mechanisms have been demonstrated 
where BCSO will inhibit the cyclooxygenase pathway and a 5-lipooksigenase through inflammatory reaction 
barrier [20], [21]. 
BCSO chemo preventive mechanisms through eNOS and NO is still uncertain, whereas NO is pleiotropic. 
The research objective was to determine the effect on the expression of eNOS BCSO and the levels of NO in 
macrophage cell culture supernatant SD rat DMBA induced. 
2. Method 
An experimental study in vivo on 36 rats SD who were divided into 6 groups, given MBJH 3 ratings dose 
(0:01, 0:05 and 0.1 ml / day), vitamin E (positive control), and induced DMBA, except normal control 
(without induced DMBA) , 
Parameters measured were culture supernatant NO levels of eNOS expression in macrophages and 
endothelial tissue. Experts conduct examination of the expression of eNOS done immuno histo chemical. 
2.1. Work Procedures 
1) Animal testing quarantined and acclimatized. Forty SD strain rats aged 2 weeks included in the 
plastic enclosure covered with woven wire. Rats are adapted for 1 week at home maintenance before 
being used for research. Test animals fed and watered in accordance standards for quarantine and 
acclimation. Acclimatization test animals were randomly divided into six groups on the sixth day [1]. 
2) The provision of treatment and DMBA induction. 
36 SD strain rats aged 3 weeks were divided into six groups, each of 6 animals after they were 
randomized. Then, the mice housed in a plastic enclosure that is covered with woven wire. Mice were 
weighed weekly during the study to determine the weight development. Group I is the normal group. 
Animal testing in this group was not given treatment. Pets only get to eat and drink during the testing 
standards. Groups II, III and IV of the treatment groups. Animal tests get BCSO doses of 0.01, 0.05 and 0.1 ml 
/ kg. Animal testing DMBA induced single dose of 15 mg / head. Group V is a negative control group. Group 
VI was the positive control group. The group get vitamin E / A or tocopherol and get a single dose of DMBA 
induction. 
3) Observations expression of eNOS 
Aorta was isolated. Aortae located at the back of the chest, above the heart. Aortae taken from the chest 
cavity after the peritoneum is opened, and after the mice anesthesia with chloroform. Aortae 
histopathological examination conducted as researchers previously with the same procedure, namely the 
procedure process of the network, with Hematoxillin & eosin staining and analysis of the results of 
histopathologic assessment. Most stocks do endothelial tissue histology staining with antibodies immuno 
histo chemical eNOS. Painting immuno histo chemical carried out according to standard procedures in 
anatomical pathology laboratory, medical faculty of the University of Gadjah Mada [1]. Mixture paintwork 
immuno histo chemical read by doctors Expert Pathology in the Faculty. 
Macrophages isolation procedures performed according previous studies [1]. Mice were placed in the 
supine position, the skin of the abdomen is opened and cleaned sheath peritoneum with 70% alcohol, then 
injected 10 ml cold RPMI medium into the peritoneal cavity, wait for 3 minutes as he rocked slowly. 
Peritoneal fluid is removed from the peritoneal cavity by tapping with two fingers in the cavity, the fluid 
aspirated with a syringe injection, selected in the lean and away from the gut. Aspirates centrifuged at 1200 
RPM, 4 ° C for 10 minutes. The supernatant was discarded, the pellets resuspended in RPMI containing 10% 
FCS. 
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The number of cells counted by hemocytometer, then added a complete medium to obtain a cell 
suspension with a density of 1 x 106 / ml. Macrophage cell counting procedures conducted according the 
general procedure. Object alcoholic glass cleaned with a tissue, then the object mounted on the tool 
according to the size of the place. Fluid macrophages stirred, then put the liquid in a sterile tube and 
pipetted into a tool in the tool hemocytometer then read interval microscope. The number of macrophages 
is calculated by cell counting with a magnification of 100 times. Cell count is performed to determine the 
number of macrophage cells contained in the cell suspension. 
Micro cultures suspension cells grown in 24 wells that have been given a round coverslips. Each of the 
wells filled in 200 microliters (2 × 105 cells). Cells were incubated in a 5% CO2 incubator, 37 ° C for 30 
minutes. Cell added a complete medium of 1 ml each of the wells and incubated 2 hours. Cells were washed 
2 times with RPMI 1 ml each of the wells and cells were incubated in complete medium for up to 24 hours 
[21]. 
Macrophage culture supernatant was collected in wells plate 36 is checked by the method Gries. 0.1 
grams of N- (1-naphthyl) ethylenediamine hydrochloride (Sigma N 5889) was dissolved in 100 mL of 
distilled water to make a solution of Griess A. The solution was stored at 0-4 ° C and protected from light. 
Griess B solution consisting of 1 gram sulfanilamide (Sigma S9251) were dissolved in 100 mL of 5% (v / v) 
orthophosphoric acid. The solution was stored at 0-4 ° C and protected from light. 10 mM solution of nitric 
standard prepared by the following procedure: 69.0 mg sodium nitrate dissolved in 100 mL of distilled 
water. The solution is stored at 0-4 ° C, protected from light. The test measures the sample is as follows: 100 
uL of sample and standard nitrite included in a 24-well microliter plate. If the sample is less than 100 uL, 
the volume is increased to 100 uL with water or medium. Samples are then added 100 uL Griess solution 
and incubated at room temperature for 15 minutes until it changes color. All samples and standards put in a 
microliter plate, and then ELISA reader measured absorbance. Absorbance measurement for a standard 
sample and performed at a wavelength of 540 nm. 
2.2. Data Analysis 
Statistical methods are used depending on the type of analysis weight development Data were analyzed 
by Anova. The analysis followed by Turkey’s test to analyze the significance difference in the average value 
of inter-group and inter-time data retrieval. Histopathology differences were analyzed by descriptive and 
inference (analytic). Statistical testing used ANOVA test to determine differences in the average number of 
gene expression, and levels between groups (p <0.05), followed by multiple test comparison. ENOS 
expression data expressed as a percentage of endothelial cell expression. eNOS expression data and NO 
levels of macrophage culture supernatant tested the mean difference between groups with a confidence 
level of 95%. Immuno histo chemical picture presented descriptively. 
3. Result 
3.1. Endothelial eNOS Expression 
Test results immuno histo chemical eNOS expression of endothelial tissue SD rat DMBA induced after 
administration BCSO presented in Table 1. 
The results showed that the DMBA induced significantly increased the expression of eNOS. ENOS 
expression in DMBA group is higher than in the normal group (P <0.05). Award BCSO decreased the 
expression of eNOS. ENOS expression in group BCSO 0:01 and 0:05 ml / kg body weight / day lower than 
the DMBA group (p <0.05), and no different from the normal group (P> 0.05). ENOS expression in group 
BCSO 0.1 ml / kg / day did not differ with DMBA group and higher than the normal group (p <0.05). eNOS 
expression vitamin E group (positive control) did not differ with different groups of DMBA and the normal 
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group (p <0.05). 
 
Table 1. eNOS Expression of Endothelial Tissue SD Rats Induced with DMBA after Getting BCSO Percentage 
of Endothelial eNOS Expression (%) 
Group N The mean expression of eNOS P1 P2 
normal control 6 12.78±9.83  0.001 
DMBA treatment + 0.01 ml / KgBW 
BCSO 
6 13.88±4.95 0.85 0.001 
DMBA treatment + 0.05 ml / KgBW 
BCSO 
5 19.06±7.11 0.33 0.002 
DMBA Treatment + 0.1 ml / KgBW 
BCSO 
6 25.68±11.31 0.04 0.01 
Negative control DMBA 4 38.82±15.94 0.001 - 
Positive control (DMBA + Vitamin 
E) 
6 27.37±11.62 0.021 0.04 
P1 = different test to the normal control group 
P2 = different test against the negative control group 
 
3.2. NO Levels in the Culture Supernatant of Macrophages 
The observation of the levels of NO in macrophage culture supernatant SD rat DMBA induced presented 
in Table 2. 
 
Table 2. Levels of NO in Macrophage Culture Supernatant SD Rat DMBA Induced after Administration BCSO 
Group N NO levels (mean ± SD) (moll / ml) P1 P2 
Normal Control 6 0.27±0.09 - 0.01 
Treatment of 0.01 ml / KgBW BCSO 6 0.29±0.10 0.77 001 
Treatment of 0.05 ml / KgBW BCSO 5 0.22±0.06 0.98 0.000 
Treatment of 0.1 ml / KgBW BCSO 6 0.29±0.15 0.77 0.002 
Negative control DMBA 4 0.58±0.18 0.001 - 
Positive Control (tocopherol) 6 0.48±0.14 0.005 0.22 
P1 = different test to the normal control group 
P2 = different test against the negative control group 
 
The results showed that the potential increase DMBA induced NO production by macrophages. Based on 
the Table 2, the levels of NO in macrophage culture supernatant SD rat DMBA group was higher than normal 
levels of NO control group, but not statistically significant (p <0.05). NO levels in the culture supernatant of 
macrophages, BCSO low-dose group (0:01 and 0:05 ml / kg) lower than in the DMBA group (p <0.05). 
4. Discussion 
Three isoforms of nitric oxide synthase (NOS) have been identified, namely endothelial NOS, neuronal 
NOS, and inducible NOS (iNOS). Although iNOS has been widely studied in the mechanism of carcinogenesis 
is exposed to carcinogens DMBA, yet eNOS test has not been performed. iNOS is an enzyme regulator of NO 
production in macrophages, whereas eNOS is the regulator of NO production in endothelial cells. The 
results showed exposure to DMBA would increase eNOS expression rat endothelial cells and NO production 
by macrophages. 
The results of the study in accordance with previous studies [11] have shown that increased expression 
of iNOS in the group that accompanied DMBA-induced mammary carcinogenesis tissue or tissues of the 
mouth. Other researchers have also proved that the DMBA induced serum NO level will enhance and 
increase carcinogenesis [22]. Giving BCSO shown to decrease serum levels of NO and reduce the risk of 
mammary cancer incidence [1]. 
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Results of in vivo study is also consistent results of epidemiological studies in which patients who have 
genetic polymorphisms of eNOS that had higher levels of NO lower than patients who did not undergo 
genetic polymorphisms of eNOS, also has a quality of life and the success of therapy was higher [23]. 
Previous research has shown that the compound has potential chemo preventive BCSO or anticancer. [1] 
proved that the hexane extract BCSO inhibit mammary carcinogenesis in rats induced SD DMBA. In 2004, 
[16] proved that BCSO ethanol extract inhibits the formation of mammary cancer. [24] demonstrated the 
effects anti clastogenic thymoquinone. In 2001, [25] proving that thymoquinone a chemo preventive for 
gastric cancer in rats induced by DMBA. In 1999, [26] also been proved that thymoquinone have anti 
fibrosarcoma.
Ignarro, 2010 [4] and Yuk-Kwan et all, 2002 [7] states that NO compounds have pleiotropic effects. At low 
doses, NO has a function as a vasodilator and cellular signaling, keeping the body homeostasis and 
angiogenesis and anti-infective. Though in large doses, Compound NO, has potential as a source of reactive 
radicals and destabilize the genetic [17], [19], [20]. Genetic changes due to oxidative stress genes 
proto-oncogene are beginning the process of carcinogenesis. Giving anti-inflammatory antioxidant 
compounds will inhibit the process of carcinogenesis [5]. Antioxidant compounds are inhibitors of eNOS 
expression that NO production is not abundant. This demonstrates the ability to decrease the incidence of 
cancers such as compound BCSO, thymoquinone [21]-[23]. Another mechanism of carcinogenesis in a 
compound suspected of NO through a mechanism immunosuppressants. NO abundant compounds have 
proven to be had imunopresan effect on lymphocytes. Effects of immunosuppressant will inhibit 
lymphocyte proliferation and diferensi thus decreasing the amount CD4Th which plays an important role as 
imunosurveilan cancer [18].
5. Conclusion 
BCSO 0,01 and 0,05 ml / kg / day can decrease endothelial eNOS expression and NO levels of macrophage 
culture supernatant SD rat DMBA induced.. 
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